SCYX · NASDAQ
SCYNEXIS (SCYX) Stock Price & Fundamentals
SCYNEXIS (SCYX) closed at $376.96 on Oct 9, 2026, up 0.74% from the previous close of $374.18.
Share price, past year
1Y +9.88%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $376.96 |
| Sep 30, 2026 | $369.58 |
| Aug 31, 2026 | $369.80 |
| Jul 31, 2026 | $357.27 |
| Jun 30, 2026 | $371.83 |
| May 29, 2026 | $370.94 |
| Apr 30, 2026 | $364.08 |
| Mar 31, 2026 | $347.76 |
| Feb 27, 2026 | $340.82 |
| Jan 30, 2026 | $355.77 |
| Dec 31, 2025 | $355.69 |
| Nov 28, 2025 | $357.72 |
| Oct 31, 2025 | $348.92 |
Key statistics
- Market cap
- $29.95B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.10
- Revenue (TTM)
- $19.22M
- Net income (TTM)
- −$10.24M
- Shares outstanding
- 79.5M
- Dividend yield
- —
- 52-week range
- $337.42 – $393.41
SCYNEXIS's market cap is $29.95B, based on a share price of $376.96 and 79.5M shares outstanding as of May 28, 2026.
Financials
SCYNEXIS reported revenue of $20.60M for fiscal 2025, up 449.95% from fiscal 2024.
SCYNEXIS reported a net loss of $8.61M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $20.60M | +450.0% | −$8.61M | −41.8% | −$1.36 | — |
| FY2024ended Dec 31, 2024 | $3.75M | −97.3% | −$21.29M | −568.3% | −$3.52 | — |
| FY2023ended Dec 31, 2023 | $140.14M | +2,652.7% | $67.04M | 47.8% | $11.12 | — |
| FY2022ended Dec 31, 2022 | $5.09M | −61.3% | −$62.81M | −1,233.7% | −$11.76 | — |
| FY2021ended Dec 31, 2021 | $13.16M | — | −$32.87M | −249.7% | −$10.00 | −$54.56M |
| FY2020ended Dec 31, 2020 | $0.00 | −100.0% | −$55.19M | — | — | −$49.36M |
| FY2019ended Dec 31, 2019 | $121.00K | −52.9% | −$53.71M | −44,388.4% | — | −$38.12M |
| FY2018ended Dec 31, 2018 | $257.00K | 0.0% | −$12.47M | −4,851.4% | — | −$28.89M |
| FY2017ended Dec 31, 2017 | $257.00K | 0.0% | −$25.06M | −9,751.0% | — | −$24.56M |
| FY2016ended Dec 31, 2016 | $257.00K | — | −$29.99M | −11,668.9% | −$126.40 | −$29.38M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $235.00K | $7.40M | $0.63 |
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$21.30M | −$3.36 |
| Q4 FY2025ended Dec 31, 2025 | $18.65M | $12.26M | $1.99 |
| Q3 FY2025ended Sep 30, 2025 | $334.00K | −$8.59M | −$1.36 |
| Q2 FY2025ended Jun 30, 2025 | $1.36M | −$6.89M | −$1.11 |
| Q1 FY2025ended Mar 31, 2025 | $257.00K | −$5.39M | −$0.88 |
| Q4 FY2024ended Dec 31, 2024 | $977.00K | −$4.43M | −$0.72 |
| Q3 FY2024ended Sep 30, 2024 | $660.00K | −$2.81M | −$0.48 |
Company profile
- Name
- SCYNEXIS, Inc.
- Ticker
- SCYX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1 Evertrust Plaza, 13th Floor, Jersey City, NJ 07302-6548
- Fiscal year ends
- December
- SEC CIK
- 0001178253
Recent SEC filings
- Sep 28, 2026
- Sep 22, 2026
- Sep 10, 2026
- Aug 10, 2026
- Jun 26, 2026
- May 29, 2026
- May 22, 2026
- May 11, 2026
Frequently asked questions
What is SCYNEXIS's stock price?
SCYNEXIS (SCYX) closed at $376.96 on Oct 9, 2026, up 0.74% from the previous close of $374.18.
What is SCYNEXIS's market cap?
SCYNEXIS's market cap is $29.95B, based on a share price of $376.96 and 79.5M shares outstanding as of May 28, 2026.
How much revenue does SCYNEXIS make?
SCYNEXIS reported revenue of $20.60M for fiscal 2025, up 449.95% from fiscal 2024.
Does SCYNEXIS pay a dividend?
SCYNEXIS's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from SCYNEXIS, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures